| Literature DB >> 35447918 |
Roberta Esposito1,2, Serena Federico1, Marco Bertolino3, Valerio Zupo1, Maria Costantini1.
Abstract
In the last decades, it has been demonstrated that marine organisms are a substantial source of bioactive compounds with possible biotechnological applications. Marine sponges, in particular those belonging to the class of Demospongiae, have been considered among the most interesting invertebrates for their biotechnological potential. In this review, particular attention is devoted to natural compounds/extracts isolated from Demospongiae and their associated microorganisms with important biological activities for pharmacological applications such as antiviral, anticancer, antifouling, antimicrobial, antiplasmodial, antifungal and antioxidant. The data here presented show that this class of sponges is an exciting source of compounds, which are worth developing into new drugs, such as avarol, a hydroquinone isolated from the marine sponge Disidea avara, which is used as an antitumor, antimicrobial and antiviral drug.Entities:
Keywords: Demospongiae; bacteria; diverse bioactivities; fungi
Mesh:
Substances:
Year: 2022 PMID: 35447918 PMCID: PMC9032870 DOI: 10.3390/md20040244
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Graphical representation of sponges and their associated biota activities reported for the pharmacological application. The scale of the bubble is relative to the number of papers found. This image was created in Biorender.com (accessed on 1 January 2022).
Figure 2Examples of natural products isolated from some sponges belonging to the class of Demospongiae.
Source, sponge host, extract/compound, cell line/organism tested and corresponding reference are reported.
| Source | Associated Organisms | Extract/Compound | Cell Line/Organism Tested | Reference |
|---|---|---|---|---|
| Topsentin and bromotopsentin | P388, HCT8, A549, T47 | [ | ||
|
| Cacospongiolide | Shrimp | [ | |
|
| Saraine A |
| [ | |
|
| Petroleum ether and total methanolic extracts | HepG2 | [ | |
|
| Aqueous ethanol extract | CACO-2 and MCF-7 | [ | |
| Geodiamolide H 3 | HOP 92, SF-268, OV Car-4, A498, UO-31, MDA-MB-231, HS 578T | [ | ||
|
| Methanolic extract | MCF-7, MDA-MB231, MDA-MB468 | [ | |
|
| Oxysterol and 4′-methylheptyl benzoate | MCF-7 and HepG2 | [ | |
|
| Fasciculatin | MCF-7, NCI-H460 and SF-268 | [ | |
| Methanolic extract | LAN5 and SK-N-BE(2)-C | [ | ||
| Aqueous extract | THP-1, CaCo-2 and BHK-21 | [ | ||
|
| Gukulenin A | A2780, SKOV3, OVCAR-3 and TOV-21G | [ | |
|
| Lectin | Jurkat leukemia T and K562 | [ | |
|
| Aqueous extract | [ | ||
|
| Aqueous cell supernatans | HeLa, SH-SY5Y and B-104-1-1 | [ | |
|
| Petrocidin A | HL-60 and HT-29 | [ | |
|
| Strepoxazine A | HL-60 | [ | |
|
| Ethil acetate extract | WiDr, T47D and HeLa | [ | |
|
| Penazetidine A | PKC | [ | |
|
| Hymenialdisines 4 and 5 | PKC | [ |
Source, sponge host, extract/compound, cell line/organism tested and reference are reported.
| Source | Associated Organisms | Isolated Compound | Cell Line/Organism Tested | Reference |
|---|---|---|---|---|
|
| Eosinophilic amoebocytes (EA) fraction | [ | ||
|
| Ethyl acetate extract |
| [ | |
| Manzamenones M and N | [ | |||
|
| Plakortide N and F |
| [ | |
|
| Methanol extract | [ | ||
|
| Methanol extract |
| [ | |
| 1 Monoamphilectine and 8,15-diisocyano-11(20)-amphilectene |
| [ | ||
| Ethyl acetate extract | [ | |||
|
| 2-(2’,4’-dibromophenoxy)-3,5-dibromophenol |
| [ | |
|
| Peptide C |
| [ | |
|
| Aqueous extractA and methanol extract B | [ | ||
|
|
| Ethyl acetate extract | [ | |
|
| Bacillus 2011SOCCUF3 | Methanol extract | [ | |
|
|
| Ethyl acetate extract | [ | |
|
| Pyrrolo(1,2-a)pyrazine-1,4-dione,hexahydro | [ | ||
|
| Proteobacteria, | Aqueous extract |
| [ |
|
| Bacterial isolates |
| [ | |
| Bacterial isolates | [ | |||
| Proteobacteria, | Bacterial isolates | [ | ||
| Bacterial isolates | [ | |||
| Bacterial isolates | [ | |||
|
| Methanol extract | [ |
Source, extract/compound, pathogens tested and corresponding references are reported.
| Source | Extract/Compound | Pathogens Tested | Reference |
|---|---|---|---|
| Aqueous, ethanol and dichloromethane extract | [ | ||
|
| Tryptamine and 6-bromo-8,1’-dihydro-isoplysin A and 5,6-dibromo-8,1’-dihydro-isoplysin A | [ | |
|
| Ethyl acetate and aqueous extracts | [ | |
|
| Ethyl acetate extract |
| [ |
|
| Kalihinenes X, Y and Z |
| [ |
| Dichloromethane extract | [ | ||
|
| Barretin and 8,9-dihydrobarretin |
| [ |
| Bastadins 3, 4, 9, bastadin-16, hemibastadin-1, aplysamine-2, psammaplin A |
| [ | |
| Acetone/dichloromethane extract |
| [ | |
| Two hexapeptides |
| [ |
Source, extract/compound, activity and corresponding reference are reported.
| Source | Sponge Host | Extract/Compound | Activity | Reference |
|---|---|---|---|---|
|
| Plakortin and Plakortide Q | Antiplasmodial | [ | |
| Monoamphilectine A | Antiplasmodial | [ | ||
|
| Ptilomycalin F and Fromiamycalin | Antiplasmodial | [ | |
|
| 8-oxo-tryptamine and ( | Antiplasmodial | [ | |
|
| Bacterial colonies THB20 and THB34 | Ethyl acetate extract | Antiplasmodial | [ |
|
| Pachymatismin | Antileishmanial | [ | |
|
| Araguspongin C | Antileishmanial | [ | |
| Hyrtiodoline A | Antitrypanosomial | [ | ||
|
| Ethanol extract | Antifungal | [ | |
|
| Untenospongin B | Antifungal | [ | |
| Psedoalteromonas, Bacillus, Vibrio and Staphylococcus phyla | Isolated of bacteria | Antifungal | [ | |
|
| Methanol extract | Antifungal | [ | |
|
| Methanolic extract | Antifungal | [ | |
|
| Peptide C | Antifungal | [ | |
|
| Plakortide N and Plakortide F | Antifungal | [ | |
| Menzamenone M and Menzamenone N | Antifungal | [ | ||
|
| Proteobacteria, Actinobacteria and Firmicutes phyla | Aqueous extract | Antifungal | [ |
| Ethyl acetate extract | Antifungal | [ | ||
|
| Collagen extract | Wound-healing | [ | |
| Collagen filaments | Wound-healing | [ |
Figure 3Different bioactive extracts/compounds isolated from Demospongiae.